Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histopathological Response”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT01116635
What this trial is testing

Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of British Columbia 24
Testing effectiveness (Phase 2)UnknownNCT02591667
What this trial is testing

Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer

Who this might be right for
Colorectal CancerPeritoneal Metastasis
Medical University of Vienna 30
Not applicableStudy completedNCT03742063
What this trial is testing

Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone

Who this might be right for
Clinical ResponseHistopathological ResponsePrognosis
Peking University People's Hospital 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT03773367
What this trial is testing

Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
Lund University Hospital 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation